Replies to post #370893 on Elite Pharmaceuticals Inc (ELTP)

[The ELTP King]

Agreed.

Wasn’t that just Doxy & Vigabatrin? Both were approved after Q3. I don’t think FDA is reviewing anything else submitted by Elite.

[kayak_wench]

Yea, in looking back over CCs I think you and aELmTPa are right, nothing else is under review. Maybe we will pull out getting one ANDA submitted before the end of calendar year. This stock is like fusion power but instead of always being 20 years out no matter what year it is we are always two years away from getting enough revenue to build share price.

I did not remember the possibility of Elite buying Nasrat's part of the Adderall that aELmTPa noted. Can we assume since we split license fees 50-50 that would gain us another 4 million a year (1.3 x 4)? That will matter if we can get and keep current sales where in the $7 to 8 million range rather than 5 to 6.